SYS-CON MEDIA Authors: Gilad Parann-Nissany, Kevin Benedict, Unitiv Blog, RealWire News Distribution, Jason Bloomberg

News Feed Item

Adlib and Generis - Life Sciences Partnership

Adlib and Generis form Strategic Partnership to extend CARA with Adlib Advanced Rendering & Publishing for Life Sciences

PRINCETON, N.J. and TORONTO, Jan. 29, 2014 /PRNewswire/ --  Adlib, the leading provider of Advanced Rendering technology, and Generis Knowledge Management, providers of leading-edge software for content management systems, today announced a strategic partnership to provide Life Sciences organizations with a more comprehensive Enterprise Content Management application for their document rendering requirements.

By utilizing Generis' CARA interface along with Adlib's automated document-to-PDF conversion technology, Life Sciences organizations will benefit from a unique combination of web-based access and powerful, enterprise-grade rendering functionality.

"Our new partnership is a win for organizations in the Life Sciences sector  as they will be able to leverage automated rendering and publishing capabilities that integrate into their Enterprise Content Management Systems, and access the capabilities through a web-based interface," commented James Kelleher, CEO, Generis.

Adlib PDF offers streamlined integration into the most commonly used Enterprise Content Management systems, including the leading repository in the Life Sciences industry, EMC Documentum.

"Life Sciences organizations that select both CARA and Adlib PDF will be able to extend their EMC Documentum deployments with automated rendering and publishing capabilities in a more robust manner  with greater ease of use for added convenience and effectiveness," stated Peter Duff, President & CEO, Adlib.

Adlib's Advanced Rendering products recently received EMC Certified Solution Partner status and offer streamlined integration with EMC Documentum.  Adlib PDF provides next-generation Advanced Rendering technology, ideal for high-volume environments where accurate, scalable and highly-available document-to-PDF conversion services are required across the enterprise. Adlib offers Life Sciences organizations numerous benefits that include the automated generation of compliant PDFs that meet regulatory requirements.

CARA is Generis' fast, web user interface and business rules engine for Documentum, Oracle WebCenter and Alfresco that facilitates the creation, review, approval and management of documents. CARA allows customers to build their own applications in hours instead of months, but Generis also offers a number of Life Sciences-specific packages with configurations to industry standards, such as CTD, eTMF, Quality/GxP, Correspondence, and Labeling.

About Generis

Generis  has been providing leading-edge software for content management systems including Documentum, SharePoint, Alfresco and Oracle WebCenter since 1997. The company has nearly 50 customers across industries from Government, through Life Sciences and Engineering to Media, Publishing and Financial. The company is headquartered in Princeton, NJ, and has its principal development centers in Europe. In addition to the market-leading CARA user interface, Generis also provides a number of add-on modules to handle data migration and import / export, annotations and hyperlinking.   For more information about Generis, visit www.generiscorp.com.

About Adlib

By automating the conversion of content, Adlib empowers over 5,500 companies to help them save millions of dollars each year. Seamless integration with leading Enterprise Content Management (ECM), Product Lifecycle Management (PLM) and Workflow solutions enable customers to streamline the rendering and assembly of PDFs within existing business processes. Learn more at www.adlibsoftware.com.

Contact

Roger Beharry Lall
Director, Product Marketing
[email protected]

PRLog ID: www.prlog.org/12273388

SOURCE Generis Knowledge Management

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.